Agilon Health, Inc. (NYSE: AGL) has announced a reverse stock split of its common stock at a ratio of 1-for-25, effective March 30, 2026. This decision follows the approval of the amendment to the company's Amended and Restated Certificate of Incorporation by its stockholders during a special meeting held on March 17, 2026. The reverse stock split aims to increase the market price of Agilon's common stock above the $1.00 minimum bid price requirement for continued listing on the New York Stock Exchange (NYSE). The company anticipates that the split will improve the marketability and liquidity of its shares, potentially attracting a broader range of investors and generating greater interest in the company. Following the split, approximately 16,605,993 shares of common stock will be outstanding. No fractional shares will be issued; instead, stockholders entitled to receive fractional shares will receive cash in lieu of such shares. The new CUSIP number for the common stock will be 00857U 206. Agilon Health is committed to empowering physicians to transform healthcare in their communities, and this strategic move is part of their ongoing efforts to enhance shareholder value and operational effectiveness.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.